Alan Spatz

18PUBLICATIONS
119CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 25, 2026
Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper.

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Nov 13, 2025
Evaluating the Role of Liquid Biopsy to Detect Pathogenic Homologous Recombination Repair (HRR) Gene Alterations in Metastatic Prostate Cancer.

Soumaya Labidi, Belinda Jiao, Shirley Tam

|Apr 08, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Dec 03, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Nov 26, 2024
Sex-Related Differences in Immunotherapy Outcomes of Patients with Advanced Non-Small Cell Lung Cancer.

Sara Frida Cohen, Diane Cruiziat, Jeremy Naimer

Pageof 3

Frequent Collaborators

3 joint publications

Christoph H Borchers

3 joint publications

Vincent Lacasse

2 joint publications

Andreas I Papadakis

2 joint publications

Sanne Marlijn Janssen